Novocure Announces Reimbursement of Optune for the Treatment of Newly Diagnosed Glioblastoma in France
Optune is now available as a treatment for newly diagnosed glioblastoma patients in France Novocure (NASDAQ:NVCR) today announced the reimbursement and availability of Optune together with temozolomide